Tag: AMR

Global Principles on Incentivizing Antibiotic R&D
Joint Statement On World Antimicrobial Awareness Week
2020: a game changer year for AMR? (Video)
Global launch highlights from Washington DC 9 July 2020
Global launch highlights from Berlin 9 July 2020
AMR Action Fund launch event in Washington DC on 9 July 2020 (Video)
Message from Thomas Cueni at AMR Action Fund launch event in Tokyo on 10 July 2020 (Video)
Launch Event 9 July | New initiative takes on the antibiotic innovation challenge (Video)
New AMR Action Fund steps in to save collapsing antibiotic pipeline with pharmaceutical industry investment of US$1 billion
AMR life science industry 2020 report: Successes and setbacks in fighting superbugs
AMR Industry Alliance 2020 progress report
AMR Position Papers
Report shows life sciences industry alliance is taking action to curb antimicrobial resistance, with more to come
AMR Industry Alliance Progress Report: Tracking Progress to Address AMR
AMR Industry Alliance Statement - Global call for action on drug-resistant infections, 12-13 October 2017, Berlin (Conference organized by Wellcome Trust)
IFPMA Statement to New Essential Medicines List
IFPMA contribution to key global health discussions @WHA70 (22-31 May 2017)
WHO WHA 70 Item A70/12 Antimicrobial resistance
Sustainable models to overcome the challenging economics of antimicrobial R&D
The Globalisation of the Pharmaceutical Industry
Global Biopharmaceutical Industry Takes Action to Combat Antimicrobial Resistance (AMR)
Industry Roadmap for Progress on Combating Antimicrobial Resistance
Leading Pharmaceutical Companies Present Industry Roadmap to Combat Antimicrobial Resistance
The R&D-based biopharmaceutical industry at the forefront of addressing AMR
AMR Industry Alliance
PAHO Foundation Project for Mobilizing and Facilitating Multi-Sector Support of AMR Control in LAC
Biopharma contributes to key global health discussions at WHA69
ABPI, EFPIA, and IFPMA issue joint statement on AMR
Declaration by the Pharmaceutical, Biotechnology and Diagnostics Industries on Combating Antimicrobial Resistance
New research-based pharmaceutical industry report provides insights on how to slow down antimicrobial resistance (AMR) and boost antibiotic R&D

Other Tags

Access Access to antiretrovirals Access to Medicines Access to vaccines Africa AMR AMR Industry Alliance Anti-Counterfeit Antibiotics antimicrobial resistance antivirals Assembly Biosimilars Biotherapeutic Medicines Biotherapeutics Cancer Clinical Trials Code of Practice collaboration Counterfeit Medicines Counterfeits COVID-19 COVID-19 vaccines Dementia Developing World Diabetes Economic footprint Efficacy Epidemics Ethics Event Highlights Fake Medicines Fakes Fight the Fakes Flu Global Health global health security harmonization Health Health Partnerships HIV/AIDS IFPMA IFPMA Statement Immunization Incremental Innovation Influenza Influenza Vaccination Infographic Infographics Innovation Innovation ecosystem Intellectual Property IP Malaria MDGs Medicines Mental and Neurological Disorders NCDs Neglected Tropical Diseases News Releases Non-Communicable Diseases Novel Coronavirus (COVID-19) NTDs pandemic Pandemic Influenza Pandemic preparedness pandemics Partnerships Pharma Pharmacovigilance Position Paper Prevention Publications Public Health Quality R&D Regulatory regulatory systems Related Links Research Safety SDGs Seasonal Influenza Statements Supply chain Sustainable Development Goals Sustainable Innovation trade Treatments Tuberculosis UHC Universal Health Coverage Vaccine Vaccines Value of Innovation Videos WHA WHO WIPO Women’s Cancers